Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Olympus ( (JP:7733) ) has provided an announcement.
Olympus has completed a major share repurchase via the Tokyo Stock Exchange’s ToSTNeT-3 system, buying back 38,948,300 common shares for roughly JPY 60 billion, effectively reaching the full monetary limit authorized by its board. This move finalizes the repurchase framework set on May 12, 2026, and signals an active capital allocation policy aimed at enhancing shareholder value and optimizing its balance sheet.
The company will cancel 29,948,300 of these treasury shares on April 30, 2027, equivalent to 2.69% of its pre-cancellation shares outstanding, while retaining a portion for future stock compensation. After cancellation, Olympus will have 1,084,537,400 shares outstanding and 22,383,184 treasury shares, modestly tightening share supply and potentially supporting earnings per share, which may be viewed positively by investors focused on capital efficiency.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a Japan-based manufacturer best known for its medical equipment, particularly endoscopes and other imaging systems used in healthcare. The company also has a presence in scientific solutions and industrial imaging, with a primary market focus on global medical technology and precision optics, competing in a highly specialized and capital-intensive sector.
Average Trading Volume: 6,650,062
Technical Sentiment Signal: Sell
Current Market Cap: Yen1730B
For detailed information about 7733 stock, go to TipRanks’ Stock Analysis page.